714 related articles for article (PubMed ID: 1714872)
21. Role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 during nonsuppurative destructive cholangitis in a mouse graft-versus-host disease model.
Howell CD; Li J; Chen W
Hepatology; 1999 Mar; 29(3):766-76. PubMed ID: 10051478
[TBL] [Abstract][Full Text] [Related]
22. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis.
Lim AG; Jazrawi RP; Ahmed HA; Levy JH; Zuin M; Douds AC; Maxwell JD; Northfield TC
Hepatology; 1994 Oct; 20(4 Pt 1):882-8. PubMed ID: 7927229
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
Graham RP; Smyrk TC; Zhang L
Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
[TBL] [Abstract][Full Text] [Related]
24. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis.
Nakanuma Y
Hepatology; 1993 Sep; 18(3):570-5. PubMed ID: 8359797
[TBL] [Abstract][Full Text] [Related]
25. New monoclonal antibodies reacting with bile ducts: further insights into the pathogenesis of bile ductular proliferation in biliary diseases.
Ayres RC; Hübscher SG; Shaw J; Garner C; Joplin R; Williams A; Neuberger JM
J Pathol; 1991 Oct; 165(2):153-61. PubMed ID: 1720818
[TBL] [Abstract][Full Text] [Related]
26. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection.
Lang T; Krams SM; Villanueva JC; Cox K; So S; Martinez OM
Transplantation; 1995 Feb; 59(4):584-9. PubMed ID: 7533349
[TBL] [Abstract][Full Text] [Related]
27. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
[TBL] [Abstract][Full Text] [Related]
28. [Intrahepatic cholangitis with presumably immunologic bases].
Klinge O
Verh Dtsch Ges Pathol; 1995; 79():198-232. PubMed ID: 8600685
[TBL] [Abstract][Full Text] [Related]
29. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.
Wang AP; Migita K; Ito M; Takii Y; Daikoku M; Yokoyama T; Komori A; Nakamura M; Yatsuhashi H; Ishibashi H
J Autoimmun; 2005 Aug; 25(1):85-91. PubMed ID: 16006099
[TBL] [Abstract][Full Text] [Related]
30. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia.
Davenport M; Gonde C; Redkar R; Koukoulis G; Tredger M; Mieli-Vergani G; Portmann B; Howard ER
J Pediatr Surg; 2001 Jul; 36(7):1017-25. PubMed ID: 11431768
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
[TBL] [Abstract][Full Text] [Related]
33. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions.
Wu CT; Eiserich JP; Ansari AA; Coppel RL; Balasubramanian S; Bowlus CL; Gershwin ME; Van De Water J
Hepatology; 2003 Oct; 38(4):1018-25. PubMed ID: 14512889
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody against lymphocyte function-associated antigen 1 inhibits the formation of primary biliary cirrhosis-like lesions induced by murine graft-versus-host reaction.
Kimura T; Suzuki K; Inada S; Hayashi A; Isobe M; Matsuzaki Y; Tanaka N; Osuga T; Fujiwara M
Hepatology; 1996 Oct; 24(4):888-94. PubMed ID: 8855193
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrhosis.
Yasoshima M; Tsuneyama K; Harada K; Sasaki M; Gershwin ME; Nakanuma Y
J Pathol; 2000 Jan; 190(1):93-9. PubMed ID: 10640998
[TBL] [Abstract][Full Text] [Related]
36. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis.
Harada K; Isse K; Kamihira T; Shimoda S; Nakanuma Y
Hepatology; 2005 Jun; 41(6):1329-38. PubMed ID: 15880426
[TBL] [Abstract][Full Text] [Related]
37. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study.
Joplin R; Lindsay JG; Hubscher SG; Johnson GD; Shaw JC; Strain AJ; Neuberger JM
Hepatology; 1991 Sep; 14(3):442-7. PubMed ID: 1714873
[TBL] [Abstract][Full Text] [Related]
38. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
Pollheimer MJ; Fickert P; Stieger B
Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
[TBL] [Abstract][Full Text] [Related]
39. Primary sclerosing cholangitis, a vanishing bile duct disease.
van Berge Henegouwen GP
Neth J Med; 1987 Aug; 31(1-2):27-35. PubMed ID: 3658059
[No Abstract] [Full Text] [Related]
40. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
